ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Parkinson disease

Parkinson disease

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

Orthostatic hypotension’s effect on cognition in Parkinson disease, testing patients with epilepsy who can drive safely, and carotid web are covered.

From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.

Ground-breaking research suggests that the gut microbiome may play a role in the pathogenesis of Parkinson disease.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.

Pages

Subscribe to Parkinson disease on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.